Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|January 28, 2005
Antistaphylococcal activity of dalbavancin, an experimental glycopeptideGengrong Lin, Kim Credito, Lois M Ednie, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Comparative antipneumococcal activities of sulopenem and other drugsKlaudia Kosowska-Shick, Lois M Ednie, Pamela McGhee, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2010
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assayGengrong Lin, Glenn A Pankuch, Lois M Ednie, et al.
Clinical Therapeutics|March 15, 2003
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agentsMihaela Peric, Frederick A Browne, Michael R Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Spiral gradient endpoint susceptibility testing: a fresh look at a neglected techniqueRocky Pong, Maureen V Boost, Margaret M O'Donoghue, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2009
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell linesSandrine Lemaire, Françoise Van Bambeke, Peter C Appelbaum, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2012
Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time killGengrong Lin, Glenn A Pankuch, Peter C Appelbaum, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococciKensuke Nagai, Todd A Davies, Michael R Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2003
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsMichael R Jacobs, David Felmingham, Peter C Appelbaum, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2008
Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strainsKim Credito, Gengrong Lin, Laura Koeth, et al.
Pageof 15